The simultaneous impacts of global trade shifts, U.S. tax reforms, and changing drug pricing policies have prompted life ...

Allan Shaw, Chief Financial Officer and Chief Business Officer at Create Medicines, is back on the Business of Biotech this week, with a temperature check on biotech funding and the IPO market.

Strong IP keeps collaboration alive, allowing companies to attract capital, strike partnerships, and bring innovations to patients, according to legal experts at Ice Miller.

Tom Wells at 4C Associates, explores the future of biologistics, or how the packaging, storage, and logistics for biologics ...

Growing up on a commune, you learn from an early age that your primary function is to serve the community. Filling gaps isn’t optional — it’s expected. I become skilled at quickly diagnosing what is ...

On this week's episode of the Business of Biotech, we're speaking with Bernard Ravina, M.D., CEO at Vima Therapeutics, a company that emerged from stealth in May with $60 million Series A financing to ...

Batch processing, both up- and downstream, has long been the dominant bioprocessing paradigm. Bioprocessing fluids are piped and transferred as a batch from one holding vessel or process equipment to ...

On this week's episode of the Business of Biotech, Anthony Japour, M.D., CEO at iTolerance, talks about his work as a physician treating infectious diseases, his CEO role in diagnostics at the height ...

Marc Tessier-Lavigne, Ph.D. (left) and Martin Makary, M.D. (right) The FDA must “cut the idle time” that exists within the agency to bring drugs to market faster, said Commissioner Martin Makary, M.D.

Clinical trials are built around time-sensitive, patient-centered moments, such as when a patient arrives for a visit or completes a key assessment. Yet too often, disconnected technologies and ...

As a CEO and a member of the Biotech CEO Sisterhood, I see a disconnect in our industry. Women are driving breakthrough innovations, leading successful companies through crisis, and delivering results ...

On this week's Business of Biotech episode — the last of our four-part series focused on South Florida — we catch up with Rich Daly, CEO at Catalyst Pharmaceuticals, a member of Life Science Leader's ...